- Corporate Officers - A
- Aggarwal Gaurav
Insider Trading History of Aggarwal Gaurav
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aggarwal Gaurav since 2012.
This trader's CIK number is 1551965.
At the time of last reporting, Aggarwal Gaurav was the Director of Sierra Oncology, Inc.. (stock ticker symbol SRRA).
Also see all insider trading activities at Sierra Oncology, Inc..
Note that in the past
Aggarwal Gaurav also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Sierra Oncology, Inc. (SRRA) by Aggarwal Gaurav
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | SRRA | 800,000 | $21,600,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Hyperion Therapeutics Inc (HPTX) by Aggarwal Gaurav
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | HPTX | 5,000 | $50,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tranzyme Inc (OCRX) by Aggarwal Gaurav
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | OCRX | 10,000 | $21,500 | 0 | $0 | 0 | $0 |
| 2015 | OCRX | 7,500 | $27,150 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Aggarwal Gaurav:
1. Sierra Oncology, Inc. (SRRA)
2. Hyperion Therapeutics Inc (HPTX)
3. Tranzyme Inc (OCRX)
Table 1. Insider trading of Sierra Oncology, Inc. (SRRA) by Aggarwal Gaurav
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-31 | SRRA | Buy | 800,000 | 27.00 | 21,600,000 |
Table 2. Insider trading of Hyperion Therapeutics Inc (HPTX) by Aggarwal Gaurav
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-07-31 | HPTX | Buy | 5,000 | 10.00 | 50,000 |
Table 3. Insider trading of Tranzyme Inc (OCRX) by Aggarwal Gaurav
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-15 | OCRX | Buy | 10,000 | 2.15 | 21,500 |
| 2015-05-06 | OCRX | Buy | 7,500 | 3.62 | 27,150 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Aggarwal Gaurav
(Director of Sierra Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.